3 completed, 2 active not recruiting, 1 not yet recruiting, 1 recruiting. 4 Phase 1, 3 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 2, Completed 2 |
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Solid Neoplasms: new trials by email Literature Review of Solid Neoplasms trials Research Report on Solid Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrating Geriatric 8 (G8) Screening and Cancer and Age Research Group (CARG) Toxicity Assessment Score Into Routine Care for Older Adults With Cancer Solid Neoplasms, Solid Tumors | Not yet recruiting | Assiut University | 100 | 2026-10-01 | 2026-09-23 | |
| Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases Preventive radiotherapy, Systemic therapy (Standard of Care)/Observation - Solid Neoplasms, Bone Metastases | Not applicable | Recruiting | Cancer Research Antwerp | 120 | 2025-02-05 | 2026-01-20 |
| A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Dazostinag, Pembrolizumab, Platinum - Solid Neoplasms | Phase 1 / Phase 2 | Completed | Takeda | 248 | 2020-07-22 | 2026-10-22 |
| Improving Informed Consent for Early Phase Anti-Cancer Trials Summary PIS and Online Video Modules - Solid Neoplasms | Not applicable | Unknown | Royal Marsden NHS Foundation Trust | 34 | 2020-06-26 | 2022-03-04 |
| A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor E7389-LF, Nivolumab - Solid Neoplasms | Phase 1 / Phase 2 | Active not recruiting | Eisai Co., Ltd. | 125 | 2019-09-05 | 2026-10-13 |
| A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) E7386 - Solid Neoplasms, Colorectal Neoplasms | Phase 1 | Active not recruiting | Eisai Co., Ltd. | 70 | 2019-03-05 | 2026-02-27 |
| Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002) MK-7162, Pembrolizumab - Solid Neoplasms | Phase 1 | Completed | Merck Sharp & Dohme LLC | 33 | 2017-12-06 | 2021-11-15 |
| Celsius TCS Hyperthermia System PMCF Trial Hyperthermia - Solid Neoplasms | Withdrawn | Celsius42 GmbH | 2016-11-01 | 2021-07-27 | ||
| Endoscopic Ultrasonography (EUS) Guided Fine Needle Aspiration Using Free Stylet 22g and 25 g Needles Endosonography guided fine needle aspiration cytology ( Cook Medical, Boston Scientific) - Solid Neoplasms | Not applicable | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 120 | 2011-12-10 | 2020-05-22 |
Neoplasms (2) · Adrenocortical Carcinoma (1) · Carcinoma, Hepatocellular (1) · Colorectal Neoplasms (1) · Desmoid Tumors (1) · Digestive System Neoplasms (1) · Frailty (1) · Gastro-enteropancreatic neuroendocrine tumor (1) · Hyperthermia (1)
Pathological Conditions, Signs and Symptoms (2) · Adenocarcinoma (1) · Adrenal Cortex Diseases (1) · Adrenal Cortex Neoplasms (1) · Adrenal Gland Diseases (1) · Adrenal Gland Neoplasms (1) · Body Temperature Changes (1) · Carcinoma (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Fibroma (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
pembrolizumab (2) · Diathermy (1) · E-7386 (1) · Fluorouracil (1) · Nivolumab (1) · Platinum (1) · Therapeutics (1)
Eisai Co., Ltd. (2) · Assiut University (1) · Cancer Research Antwerp (1) · Celsius42 GmbH (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Merck Sharp & Dohme LLC (1) · Royal Marsden NHS Foundation Trust (1) · Takeda (1)
Canada (3) · Japan (3) · Israel (2) · United Kingdom (2) · United States (2) · Austria (1) · Belgium (1) · China (1) · France (1) · Poland (1) · Puerto Rico (1) · South Korea (1) · Switzerland (1)
Anand V Sahai, MD (1) · Charlotte Billiet, MD, PhD (1) · Juanita Lopez, MRCP PhD (1)
PMID 19032453, PMID 19418399, PMID 19669880, PMID 19997511, PMID 21327919, PMID 21592873, PMID 21611946, PMID 34489282, PMID 36923556, PMID 38295160, PMID 39516370, PMID 41888610
2017 (1), 2023 (1)